← Back to screener

CLOROX CO /DE/ CLX

Rank #1651 · NYSE · $10.6B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
44.9
P/E
71.4
P/B
32.44
ROE
45.4%
Op. Margin
–%
Debt Ratio
1603%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E 71.4x, P/B 32.44x. Ranks in the top 74% of the universe.

Profitability ★★★★★
Excellent

ROE 45.4%. Ranks in the top 9% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 1603%. Ranks in the top 97% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★☆☆☆
Average

Revenue growth of 4.0% year over year. Ranks in the top 52% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011––$0.5B$0.1B–5380
2012––$0.6B$-0.1B–-4941
2013$5.2B–$0.6B$-0.1B–-3326
2014––$0.5B$-0.1B–-4843
2015––$0.6B$-0.1B–-3040
2016––$0.6B$0.1B–2771
2017––$0.6B$0.2B–2736
2018$5.5B–$0.6B$0.1B–3416
2019$5.7B–$0.6B$0.3B–1459
2020$5.8B–$0.6B$0.5B–841
2021$6.0B–$0.7B$0.9B–584
2022$6.7B–$0.9B$0.4B–1397
2023$7.3B–$0.7B$0.6B–976
2024$7.1B–$0.5B$0.2B–2526
2025$7.4B–$0.1B$0.3B–1603

← See the full screener